Efficacy and safety of garsorasib in patients with KRAS G12C-mutated advanced pancreatic cancer
- DOI
- 10.1038/s41416-025-03286-w
- Published
- 2025-12-04
- Container
- British Journal of Cancer
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41416-025-03286-w,
title = {Efficacy and safety of garsorasib in patients with KRAS G12C-mutated advanced pancreatic cancer},
author = {Noboru Yamamoto and Dong Yan and Vinod Ganju and Xinfang Hou and Hongming Pan and Jianzhen Shan and Liwei Wang and Sang-We Kim and Gary Richardson and Rachel E. Sanborn and Jingdong Zhang and Ziyong Xiang and Wenjia Wang and Zhe Shi and Ling Zhang and Yaolin Wang and Rui-Hua Xu},
year = {2025},
journal = {British Journal of Cancer},
doi = {10.1038/s41416-025-03286-w},
url = {https://doi.org/10.1038/s41416-025-03286-w}
}RIS
TY - JOUR TI - Efficacy and safety of garsorasib in patients with KRAS G12C-mutated advanced pancreatic cancer AU - Noboru Yamamoto AU - Dong Yan AU - Vinod Ganju AU - Xinfang Hou AU - Hongming Pan AU - Jianzhen Shan AU - Liwei Wang AU - Sang-We Kim AU - Gary Richardson AU - Rachel E. Sanborn AU - Jingdong Zhang AU - Ziyong Xiang AU - Wenjia Wang AU - Zhe Shi AU - Ling Zhang AU - Yaolin Wang AU - Rui-Hua Xu PY - 2025 JO - British Journal of Cancer DO - 10.1038/s41416-025-03286-w UR - https://doi.org/10.1038/s41416-025-03286-w ER -
APA
Yamamoto, N., Yan, D., Ganju, V., Hou, X., Pan, H., Shan, J., Wang, L., Kim, S., Richardson, G., Sanborn, R. E., Zhang, J., Xiang, Z., Wang, W., Shi, Z., Zhang, L., Wang, Y., & Xu, R. (2025). Efficacy and safety of garsorasib in patients with KRAS G12C-mutated advanced pancreatic cancer. British Journal of Cancer. https://doi.org/10.1038/s41416-025-03286-w
Source records
- crossref · retrieved 2026-09-25T21:30:38.074Z